Close Menu

Tailored to You

In this segment, NPR's Morning Edition discusses personalized medicine. Wendy Kaufmann chats with Iverson Genetics Diagnostics about its warfarin testing, with Wharton's Mark Pauly about the auspicious timing of the advent of genetic testing for drugs, and with Harvard's Raju Kucherlapati about the growth of the genetic testing market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.